HIV and Hepatitis.com

HIV-HCV Coinfection

Hepatitis C Main Section
HIV and AIDS Main Section
New International Guidelines for Management of HIV-HCV Coinfection

----

Top New HIV-HCV Coinfection Articles
•	Treatment of Patients with HIV-HCV Coinfection: An Overview
•	Liver Transplant Outcomes in HIV Positive Patients with Viral Hepatitis - 4/29/08
•	Altered Cytokine Levels May Explain More Rapid Liver Fibrosis Progression in HIV-HCV Coinfected Individuals - 4/15/08
•	Prevalence and Outcomes of Liver Cirrhosis in HIV Positive People - 4/11/08
•	Deaths Due to Hepatitis C Have Increased Dramatically over the Past Decade - 4/04/08
•	Liver Steatosis Is Common in People with HIV-HCV Coinfection and Is Linked to Advanced Fibrosis - 4/01/08
•	New Network Will Send Drug Alerts Instantly to U.S. Doctors via Email - 4/01/08
•	Severe Weight Loss Can Be a Side Effect of Interferon-based Therapy in HIV-HCV Coinfected Patients - 3/28/08
•	Liver Steatosis and its Effect on Hepatitis C Treatment in HIV-HCV Coinfected Individuals - 3/21/08
•	Acute HIV-HCV Coinfection Increasingly Common in U.K.; Sexually Transmitted HCV Superinfection Reported in France - 3/18/08
•	Researchers Uncover Clues to How HIV Promotes Hepatitis C Virus Replication - 3/14/08
•	Cyclophilin Inhibitor Debio-025 Demonstrates Potent Anti-HCV Activity in HIV-HCV Coinfected Patients - 3/14/08
•	Insulin Resistance Reduces the Likelihood of Sustained Response to Hepatitis C Treatment in HIV-HCV Coinfected Patient - 3/11/08
•	Liver Fibrosis Progression in HIV-HCV Coinfected Patients Treated with Interferon plus Ribavirin - 3/11/08
•	Survival and Recurrence of Hepatitis C after Liver Transplantation in HIV-HCV Coinfected Patients - 3/07/08
•	Treatment of Acute Hepatitis C in HIV Positive Individuals - 3/04/08
	Do HIV-HCV Coinfected Patients Have Impaired CD4 Cell Recovery after Starting HAART - 2/29/08
•	Race, but Not HIV Status, Affects Early Hepatitis C Viral Kinetics - 2/22/08
•	Better Response to Hepatitis C Therapy in Coinfected Patients Taking Tenofovir (Viread), but Worse with AZT (Retrovir) or Abacavir (Ziagen) - 2/19/08
•	MELD Score Is the Best Predictor of Outcomes among HIV Positive Liver Transplant Recipients - 2/19/08
•	Vicriviroc Is Safe in HIV-HCV Coinfected Patients, but Does Not Show Activity against HCV - 2/15/08
•	Rates and Risk Factors for Liver Fibrosis Progression in HIV-HCV Coinfected Individuals - 2/15/08
	Long-term Pegylated Interferon Maintenance Therapy Demonstrates No Benefit in HIV-HCV Coinfected Patients - 2/12/08
•	Re-emergence of HCV in British Gay Men Appears to Be Reinfection, Not Late Relapse - 2/12/08
•	Sustained Response to Pegylated Interferon plus Ribavirin Reduces Liver Disease and Death in HIV Positive Patients - 2/08/08
•	Rapid Liver Fibrosis Progression in HIV Positive Men with Acute HCV Infection - 2/05/08
•	Fibrosis Status of HIV-HCV Coinfection Patients with Normal ALT Levels - 2/05/08
•	HIV Entry into Hepatic Stellate Cells Promotes Liver Fibrosis Progression - 2/05/08
•	AZT (Retrovir) Ups Anemia Risk in HIV-HCV Coinfected Patients, But Rate Remains Low - 2/01/08
•	Elevated Risk of Hepatitis-related Death in HIV-HCV Coinfected Drug Users - 1/29/08
•	GBV-C Protects against Liver Disease Progression in HIV-HCV Coinfected Individuals - 1/25/08
•	Impaired Anger Control Is a Possible Side Effect of Hepatitis C Treatment in HIV-HCV Coinfected Patients - 1/18/08
•	Nevirapine (Viramune) Is Linked with Reduced Liver Fibrosis Progression in HIV-HCV Coinfected Patients - 1/14/08
•	Accelerated Liver Disease Progression in HIV-HCV Coinfected Patients May Be Due to Increased Liver Inflammation - 1/11/08
•	Undetectable HCV Viral Load at Week 4 of Pegylated Interferon plus Ribavirin Predicts Sustained Response in HIV-HCV Coinfected Patients - 1/11/08
•	Effect of Baseline CD4 Cell Count on Efficacy and Safety of Pegylated Interferon plus Ribavirin in HIV-HCV Coinfected Patients - 1/04/08
•	Liver Steatosis Is Common among HIV Positive People, even without Hepatitis C Coinfection - 12/14/07
•	Antiretroviral Therapy Improves Poor Prognosis among HIV-HCV and HIV-HBV Coinfected Patients with Liver Cirrhosis - 12/14/07
•	Studies Look at Triple or Quadruple Infection with HBV, HCV, and HDV in HIV Positive Individuals - 12/11/07
•	HCV Coinfection Is Linked to Diabetes in HIV Positive Patients without Other Risk Factors - 12/11/07
•	Liver Enzyme Elevation and Immune Reconstitution in HIV Patients with and without Hepatitis B or C Coinfection - 12/07/07
•	Early Anti-HCV Activity of Pegasys and PegIntron Are Similar in HIV-HCV Coinfected Patients - 12/04/07
•	Sexual Transmission of HCV among HIV Positive Men Who Have Sex with Men in France - 11/30/07
•	Weight-based Ribavirin Increases Sustained Response Rate among HIV-HCV Coinfected Genotype 1 Patients, but also Raises Risk of Anemia - 11/30/07
•	Similar Response Rates and Disease Progression in HIV-HCV Coinfected and HCV Monoinfected Patients - 11/27/07
•	Biological Mechanisms Underlying Accelerated Liver Disease Progression in HIV-HCV Coinfected Individuals - 11/27/07
•	Retreatment with Pegylated Interferon alfa-2a (Pegasys) plus Weight-based Ribavirin in HIV-HCV Coinfected Non-responders and Relapsers to Prior Hepatitis C Treatment: The PILOT-NR Study - 11/20/07
•	Boosted Fosamprenavir (Lexiva) Linked to Increased Anti-HCV Immune Response and Lower HCV Viral Load in HIV-HCV Coinfected Patients - 11/16/07
•	Abacavir (Ziagen) in HAART Regimen May Reduce Response to Hepatitis C Treatment in Coinfected Individuals - 11/16/07
•	HIV-HCV Coinfected Individuals Less Likely to Spontaneously Clear HCV During Acute Infection - 11/16/07
•	Two Studies Show Rapid Liver Fibrosis Progression in HIV-HCV Coinfected Patients - 11/13/07
•	High Rate of Illness and Death in HIV-HCV Coinfected Patients with Advanced Liver Disease, but Hepatitis C Treatment Lowers the Risk - 11/13/07
•	Treatment with Interferon-based Therapy Reduces the Risk of End-stage Liver Disease in HIV-HCV Coinfected Patients - 11/13/07
•	58th Annual Meeting of the American Association for the Study of Liver Diseases (AASLD) Set for Boston, November 2-6, 2007 - 10/26/07
•	Changing Factors Associated with "Real Life" Treatment of Hepatitis C in HIV-HCV Coinfected Patients - 10/26/07
•	Interferon/ribavirin Decreases Liver Enzyme Levels and May Enable Re-initiation of Antiretroviral Therapy in HIV-HCV Coinfected Patients with HAART-related Liver Injury- 10/23/07
•	Presentation and Outcome of Hepatocellular Carcinoma in HIV Patients - 10/16/07
•	Rapid Virological Response at 4 Weeks Predicts Sustained Response in HIV-HCV Coinfected Patients Treated with Pegylated Interferon plus Ribavirin - 10/12/07
•	Pegylated Interferon Demonstrates Activity against both HCV and HIV in Coinfected Patients - 10/12/07
•	Low Prevalence of Hepatitis C Virus Antibodies in Men Who Have Sex With Men Who Do Not Inject Drugs - 10/05/07
•	Successful Hepatitis C Treatment Reduces the Risk of Liver Toxicity Caused by Antiretroviral Drugs - 10/03/07
•	HAART -- Especially Nevirapine -- May Slow Progression of Liver Fibrosis in HIV-HCV Coinfected Individuals - 9/25/07
•	Rapid HCV Clearance after 4 Weeks on Pegylated Interferon Plus Ribavirin Is the Best Predictor of Sustained Virological Response - 9/25/07
•	Predictors of Advanced Liver Fibrosis in an Urban Cohort of HIV-HCV Coinfected Patients - 9/21/07
•	Pegasys Versus PegIntron for Combination Hepatitis C Treatment of HIV-HCV Coinfected Patients - 9/21/07
•	Hepatitis B and Hepatitis C Coinfection among HIV Positive Individuals in South India - 9/21/07
•	HCV and HIV Infection Stimulate Distinct Immune Response Patterns - 9/18/07
•	Profile of Patients Triply Infected with HIV, HBV, and HCV in the HAART Era - 9/18/07
•	HIV Positive Children Are Also Likely to Be Infected with Hepatitis B or C Viruses - 9/14/07
•	Nevirapine (Viramune) Hypersensitivity Reaction Increases the Risk of Death in HIV/HCV Coinfected Individuals - 9/11/07
•	Clinical Progression of HCV-related Chronic Liver Disease in HIV Patients Receiving HAART - 9/07/07
•	Hepatitis C Virus in the Brain May Impair Cognitive Function in HIV-HCV Coinfected People - 9/07/07
•	Factors that Predict Sustained Response to Hepatitis C Treatment in HIV-HCV Coinfected Individuals - 8/31/07
•	Chronic Hepatitis B Improves the Chances of Spontaneous HCV Clearance in HIV Positive Patients with Hemophilia - 8/28/07
•	Liver Fibrosis Increases the Risk of Antiretroviral Drug Toxicity - 8/24/07
•	"Friendly" NRTIs or NRTI-sparing Regimens Improve Response to Hepatitis C Treatment in HIV-HCV Coinfected People - 8/24/07
•	Risk Factors for Mother-to-child Transmission of Hepatitis C Virus - 8/21/07
•	CD4 Cell Count Preferred over CD4 Cell Percentage for Monitoring HIV Disease Progression in People with Cirrhosis - 8/21/07
•	Rapid Response to Hepatitis C Treatment Predicts Cure, but Occurs Less Often in HIV-HCV Coinfected Patients - 8/21/07
•	Immunological Progression of HIV Disease in HIV-HCV Coinfected Patients on HAART - 8/17/07
•	Pegylated Interferon plus Ribavirin Slows Liver Cirrhosis Progression in HIV-HCV Coinfected Individuals, Even if Non-responders - 8/17/07
•	Comparison of Non-invasive Methods for Assessing Liver Fibrosis in HIV-HCV Coinfected Individuals - 8/14/07
•	Studies Examine Occult HBV Infection in HIV Positive and HIV-HCV Coinfected Patients - 8/14/07
•	Safety of Atazanavir (Reyataz) in HIV-HBV and HIV-HCV Coinfected Patients with Pre-existing Liver Disease - 8/10/07
•	Risk of Liver Toxicity in HIV Patients Treated with Tipranavir (Aptivus) is Related to Hepatitis C Coinfection and Liver Fibrosis - 8/10/07
•	Successful Treatment of Chronic Hepatitis C Reduces the Risk of Antiretroviral-related Liver Toxicity in HIV-HCV Coinfected Patients - 8/10/07

Website Sponsor

FDA-approved Hepatitis C Treatments

Intron A
Roferon
Infergen
Pegasys
PEG-Intron
Pegasys + Copegus
PEG-Intron + Rebetol
Intron A + Rebetol
Roferon A + Ribavirin

FDA-approved HIV and
AIDS Treatments

Protease Inhibitors